Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

679444.pdf (164.94 KB)

Document type

Article

Version

Published version

Publication date

2017-07-20

Publication license

cc-by (c) Ciruela Alférez, Francisco et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/121982

Special issue: adenosine receptors

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.3390/molecules22071220

Abstract

Nearly 90 years ago, Drury and Szent-Györgyi revealed that adenosine produced profound hypotension and bradycardia, and it affected kidney function in mammals [1]. Since then, the physiological role and potential therapeutic use of adenosine have been extensively explored [2,3]. Adenosine is considered a retaliatory metabolite [4], thus increasing oxygen supply and decreasing oxygen consumption.

Subject

Adenosina, Receptors neurals, Purines, Batecs cardíacs

Subject (English)

Adenosine, Neural receptor, Purines, Heart beat

Citation

Collections

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

CIRUELA ALFÉREZ, Francisco and SOTELO, Eddy. Special issue: adenosine receptors. Molecules. 2017. Vol. 22, num. 7, pags. 1220. ISSN 1420-3049. [consulted: 17 of August of 2026]. Available at: https://hdl.handle.net/2445/121982

Export metadata

JSON - METS

Share record